These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16802000)

  • 1. Coronary artery disease progression is associated with C-reactive protein and conventional risk factors but not soluble CD40 ligand.
    Liang KW; Sheu WH; Lee WL; Liu TJ; Ting CT; Chen YT; Lee WJ
    Can J Cardiol; 2006 Jun; 22(8):691-6. PubMed ID: 16802000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes exacerbates angiographic coronary lesion progression in subjects with metabolic syndrome independent of CRP levels.
    Liang KW; Lee WJ; Lee WL; Chen YT; Ting CT; Sheu WH
    Clin Chim Acta; 2008 Feb; 388(1-2):41-5. PubMed ID: 17967444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease.
    Lee WL; Lee WJ; Chen YT; Liu TJ; Liang KW; Ting CT; Huey-Herng Sheu W
    Metabolism; 2006 Aug; 55(8):1029-34. PubMed ID: 16839837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiography.
    Rondina MT; Lappé JM; Carlquist JF; Muhlestein JB; Kolek MJ; Horne BD; Pearson RR; Anderson JL
    Cardiology; 2008; 109(3):196-201. PubMed ID: 17726321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
    Tayebjee MH; Lip GY; Tan KT; Patel JV; Hughes EA; MacFadyen RJ
    Am J Cardiol; 2005 Aug; 96(3):339-45. PubMed ID: 16054454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased circulating protective adiponectin level is associated with angiographic coronary disease progression in patients with angina pectoris.
    Liang KW; Sheu WH; Lee WL; Liu TJ; Ting CT; Hsieh YC; Wang KY; Chen YT; Lee WJ
    Int J Cardiol; 2008 Sep; 129(1):76-80. PubMed ID: 17651832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating CD40 ligand is elevated only in patients with more advanced symptomatic peripheral arterial diseases.
    Lee WJ; Sheu WH; Chen YT; Liu TJ; Liang KW; Ting CT; Lee WL
    Thromb Res; 2006; 118(5):619-26. PubMed ID: 16356539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study).
    Pan HC; Sheu WH; Lee WJ; Lee WL; Liao YC; Wang KY; Lee IT; Wang JS; Liang KW
    Clin Chim Acta; 2015 May; 445():93-100. PubMed ID: 25818243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylcholine-induced coronary spasm in patients with unobstructed coronary arteries is associated with elevated concentrations of soluble CD40 ligand and high-sensitivity C-reactive protein.
    Ong P; Carro A; Athanasiadis A; Borgulya G; Schäufele T; Ratge D; Gaze D; Sechtem U; Kaski JC
    Coron Artery Dis; 2015 Mar; 26(2):126-32. PubMed ID: 25405929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcoronary concentration gradient of sCD40L and hsCRP in patients with coronary heart disease.
    Wang Y; Li L; Tan HW; Yu GS; Ma ZY; Zhao YX; Zhang Y
    Clin Cardiol; 2007 Feb; 30(2):86-91. PubMed ID: 17326063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum pentraxin 3 levels are associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris.
    Karakas MF; Buyukkaya E; Kurt M; Motor S; Akcay AB; Buyukkaya S; Karakas E; Bilen P; Sen N
    J Investig Med; 2013 Feb; 61(2):278-85. PubMed ID: 23237880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between serum high sensitivity C-reactive protein with angiographic severity of coronary artery disease and traditional cardiovascular risk factors.
    Tajfard M; Tavakoly Sany SB; Avan A; Latiff LA; Rahimi HR; Moohebati M; Hasanzadeh M; Ghazizadeh H; Esmaeily H; Doosti H; Taghipour A; Ghayour-Mobarhan M; Ferns GA; Emamian M; Bin Abd Mutalib MS
    J Cell Physiol; 2019 Jul; 234(7):10289-10299. PubMed ID: 30548615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is soluble CD40 ligand a mediator of angiogenesis in patients with coronary artery disease?
    Lim HS; Tayebjee MH; Tan KT; Patel JV; Macfadyen RJ; Lip GY
    Thromb Res; 2008; 122(3):307-13. PubMed ID: 18054068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial changes in circulating concentrations of soluble CD40 ligand and C-reactive protein in patients with unstable angina undergoing coronary stenting.
    Yip HK; Wu CJ; Yang CH; Chang HW; Fang CY; Hung WC; Hang CL
    Circ J; 2005 Aug; 69(8):890-5. PubMed ID: 16041155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein.
    Guldiken S; Demir M; Arikan E; Turgut B; Azcan S; Gerenli M; Tugrul A
    Thromb Res; 2007; 119(1):79-84. PubMed ID: 16476470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients with stable coronary artery disease.
    Azar RR; Kassab R; Zoghbi A; Aboujaoudé S; El-Osta H; Ghorra P; Germanos M; Salamé E
    Am Heart J; 2006 Feb; 151(2):521.e1-521.e4. PubMed ID: 16442924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory biomarkers in coronary artery disease.
    Zakynthinos E; Pappa N
    J Cardiol; 2009 Jun; 53(3):317-33. PubMed ID: 19477372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
    Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
    Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes.
    Pu LJ; Lu L; Xu XW; Zhang RY; Zhang Q; Zhang JS; Hu J; Yang ZK; Ding FH; Chen QJ; Lou S; Shen J; Fang DH; Shen WF
    Cardiovasc Diabetol; 2006 Dec; 5():27. PubMed ID: 17178005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.